Eu website

    • [DOC File]Template

      https://info.5y1.org/eu-website_1_9d9f77.html

      EMA/334808/2014 . Compliance and Inspections Department . Qualified Person’s declaration concerning GMP compliance of the active substance manufacture “The QP declaration template”

      official eu website


    • [DOC File]EVVET System failure procedures - Pharmacovigilance

      https://info.5y1.org/eu-website_1_9d965d.html

      No Website Impossibility to access to generic pharmacovigilance information in the veterinary domain Yes Send message 2 weeks in advance No Send message if foreseen downtime > 8 hours B. Procedures: B.1 Prolonged failure of EudraVigilance Gateway

      countries in the eu


    • [DOC File]Europass CV - European Union External Action

      https://info.5y1.org/eu-website_1_1cdd28.html

      Replace with dates (from - to) Replace with occupation or position held Replace with employer’s name and locality (if relevant, full address and website) Replace with main activities and responsibilities Business or sector. Replace with type of business or sector. EDUCATION AND TRAINING [Add separate entries for each course.

      european union website


    • [DOC File]Declaration of the End of Trial Form (cf

      https://info.5y1.org/eu-website_1_9c941b.html

      Declaration of the End of Trial Form (cf. Section 4.2.1 of the Detailed guidance on the request to the competent authorities for authorisation of a clinical trial on a medicinal product for human use, the notification of substantial amendments and the declaration of the end of the trial)

      what is the eu


    • Europass CV

      Replace with employer’s name and locality (if relevant, full address and website) Replace with main activities and responsibilities Business or sector Replace with type of business or sector

      european union


    • [DOC File]CHMP & Rapporteurs assessment report template on ...

      https://info.5y1.org/eu-website_1_e4e6b5.html

      According to Article 8(1) of Regulation (EC) No 141/2000, where a marketing authorisation in respect of an orphan medicinal product is granted, the Union and the Member States shall not, for a period of 10 years, without prejudice to intellectual property law or any other provision of European Union law, accept another application for a ...

      eu headquarters building


    • [DOCX File]2.3 PSUR RMS AR template - Heads of Medicines Agencies

      https://info.5y1.org/eu-website_1_6f2d41.html

      As a reminder, the PSUR is not the appropriate procedure for submitting final or interim study reports to the EU regulatory authorities. These reports should be submitted and assessed via the appropriate procedure in line with the Variations Classification guideline of Commission Regulation 1234/2008.

      eu website in english


    • [DOCX File]Form for submission of comments - EFPIA

      https://info.5y1.org/eu-website_1_b4e7a4.html

      info@ema.europa.eu. Website. www.ema.europa.eu. 26 May 2015. Submission of comments on 'Draft qualification opinion of qualification of exacerbations of chronic pulmonary disease tool (EXACT), and EXACT-respiratory symptoms measure (E-RS) for evaluating treatment outcomes in clinical trials in chronic pulmonary disease’ - EMA/CHMP/SAWP/178465 ...

      supreme eu website


    • [DOCX File]Application form EN - European Union External Action

      https://info.5y1.org/eu-website_1_1fba05.html

      EUROPEAN COMMISSION. JUNIOR PROFESSIONALS . IN DELEGATION . HIGH LEVEL TRAINEESHIP PROGRAMME. Pursuant to the Joint Decision of the European Commission and the High Representative of the European Union of 12.06.2012 establishing a High Level Traineeship Programme in the Delegations of the European Union and the decision of the Chief Operating Officer of the …

      official eu website


    • [DOCX File]NOTIFICATION

      https://info.5y1.org/eu-website_1_b22c9e.html

      European Union; If applicable, name of local government involved (Article 3.2 and 7.2): 2. Agency responsible: European Commission. Name and address (including telephone and fax numbers, email and website addresses, if available) of agency or authority designated to handle comments regarding the notification shall be indicated if different from ...

      countries in the eu


Nearby & related entries: